Article(id=1304140191510323879, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304140186485543391, articleNumber=null, orderNo=null, doi=10.7501/j.issn.0253-2670.2026.03.012, pmid=null, cstr=null, oa=null, hot=0, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1759507200000, receivedDateStr=2025-10-04, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1788860851409, onlineDateStr=2026-09-08, pubDate=null, pubDateStr=null, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1788860851409, onlineIssueDateStr=2026-09-08, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1788860851409, creator=13701087609, updateTime=1788860851409, updator=13701087609, issue=Issue{id=1304140186485543391, tenantId=1146029695717560320, journalId=1302319053441957962, year='2026', volume='57', issue='3', pageStart='789', pageEnd='1208', issueExtLink='null', onlineDate='null', pubDate='1770825600000', pubDateStr='2026-02-12', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1788860850211, creator='13701087609', updateTime=1788860942564, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1304140573955351430, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304140186485543391, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1304140573955351431, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304140186485543391, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=925, endPage=934, ext={EN=ArticleExt(id=1304140191858451114, articleId=1304140191510323879, tenantId=1146029695717560320, journalId=1302319053441957962, language=EN, title=Tongmai Yangxin Pill mitigates myocardial ischemia-reperfusion injury through enhancement of PGC-1α-mediated mitochondrial function, columnId=null, journalTitle=Chinese Traditional and Herbal Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=Objective To elucidate how Tongmai Yangxin Pill (通脉养心丸, TMYX) confers cardioprotective effects during myocardial ischemia/reperfusion injury (MI/RI) through the regulation of peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α)-mediated mitochondrial function. Methods A hypoxia-reoxygenation (H/R) model in cardiomyocytes was established. After intervention with TMYX, intracellular reactive oxygen species (ROS) levels were measured using DCFH-DA and MitoSOXTM red fluorescent probes. Cellular adenosine triphosphate (ATP) content was quantified using an enhanced ATP assay kit. Changes in mitochondrial membrane potential were evaluated by JC-1 staining. Mitochondrial respiratory function was assessed using Seahorse XF cell mitochondrial stress test. Mitochondrial morphology and ultrastructural alterations were examined using MitoTracker staining and transmission electron microscopy. Western blotting and qRT-PCR were used to determine the expression levels of proteins and genes associated with mitochondrial fusion and fission [mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), fission 1 (Fis1), dynamin-related protein 1 (Drp1)], biogenesis [nuclear respiratory factor 1 (Nrf1), mitochondrial transcription factor A (TFAM), mitochondrial DNA (mtDNA) copy number] and autophagy [Beclin1, PTEN-induced putative kinase 1 (PINK1), Parkin, p62]. To further investigate the effects of TMYX on the above-mentioned functions of H9c2 cells after PGC-1α silencing expression through PGC-1α siRNA transfection experiment. Results Compared with model group, TMYX significantly enhanced mitochondrial ATP synthesis (P < 0.01), improved mitochondrial membrane potential (P < 0.01), reduced oxidative stress (P < 0.01), and promoted mitochondrial autophagy (P < 0.05, 0.01). After silencing PGC-1α, the protective effect of TMYX on mitochondrial function was significantly weakened (P < 0.05, 0.01). Conclusion TMYX could effectively improve mitochondrial dysfunction and morphological changes induced by MI/RI by regulating mitochondrial biosynthesis, dynamic balance and autophagy through PGC-1α. This study reveals PGC-1α as a core factor regulating mitochondrial function and its potential therapeutic value in MI/RI, providing new ideas for the treatment of MI/RI., authors=YU Lu, WANG Xu, LIU Yutong, GAO Shan, YU Chunquan, LI Lin, authorsList=YU Lu, WANG Xu, LIU Yutong, GAO Shan, YU Chunquan, LI Lin, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1304140191782953641, articleId=1304140191510323879, tenantId=1146029695717560320, journalId=1302319053441957962, language=CN, title=通脉养心丸通过增强PGC-1α介导的线粒体功能减轻心肌缺血再灌注损伤, columnId=1304140191707456168, journalTitle=中草药, columnName=药理与临床, runingTitle=null, highlight=null, articleAbstract=目的 阐明通脉养心丸通过调节过氧化物酶体增殖物激活受体γ共激活因子-1α(peroxisome proliferator-activated receptor gamma coactivator-1α,PGC-1α)介导的线粒体功能从而发挥心肌缺血/再灌注损伤(myocardial ischemia-reperfusion injury,MI/RI)保护作用的机制。方法 构建缺氧复氧(hypoxia-reoxygenation,H/R)心肌细胞模型,给予通脉养心丸干预后,采用DCFH-DA和MitoSOXTM Red荧光探针检测细胞内活性氧(reactive oxygen species,ROS)水平;采用增强型三磷酸腺苷(adenosine triphosphate,ATP)检测试剂盒检测ATP水平;JC-1染色观察线粒体膜电位变化;采用Seahorse XF细胞线粒体压力测试分析线粒体呼吸功能;Mitotracker与透射电镜观察线粒体的形态与结构变化;采用Western blotting与qRT-PCR检测线粒体融合分裂[线粒体融合素1(mitofusin 1,Mfn1)、线粒体融合素2(mitofusin 2,Mfn2)、线粒体分裂蛋白1(fission 1,Fis1)、动力相关蛋白1(dynamin-related protein 1,Drp1)]、生物合成[核呼吸因子1&(nuclear respiratory factor 1,Nrf1)、线粒体转录因子A(mitochondrial transcription factor A,&TFAM)、线粒体DNA(mitochondrial DNA,mtDNA)拷贝数]及自噬[Beclin1、PTEN诱导激酶1(PTEN-induced putative kinase 1,PINK1)、帕金蛋白(Parkin)、p62]相关蛋白和基因的表达水平。通过PGC-1α siRNA转染实验进一步观察通脉养心丸对PGC-1α沉默表达后H9c2细胞上述功能的影响。结果 与模型组比较,通脉养心丸显著增强线粒体ATP合成(P<0.01),改善线粒体膜电位(P<0.01),减少氧化应激(P<0.01),并促进线粒体自噬(P<0.05、0.01)。沉默PGC-1α后,通脉养心丸对线粒体功能的保护作用显著削弱(P<0.05、0.01)。结论 通脉养心丸能够通过PGC-1α调控线粒体的生物合成、动态平衡及自噬,从而有效改善MI/RI引发的线粒体功能紊乱与形态结构变化。揭示了PGC-1α作为线粒体功能调控的核心因子,其在MI/RI中的潜在治疗价值,为MI/RI的治疗提供了新的思路。, authors=于鲁1, 王旭2, 刘雨桐1, 高杉1, 于春泉1, 李琳1, authorsList=于鲁, 王旭, 刘雨桐, 高杉, 于春泉, 李琳, authorCompany=1 天津中医药大学, 天津 301617;
2 河北工程大学附属医院, 河北 邯郸 056000, correspAuthors=于春泉, authorNote=于鲁: 于鲁,博士研究生,研究方向为中医药治疗心脑血管疾病临床与基础研究。E-mail:yuluyulu2021@163.com, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=DDWt5b0ch23Fml2j91nD4A==, pdfFileSize=2216765, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=国家自然科学基金青年科学基金资助项目(82104565);天津中医药大学组分中药国家重点实验室青苗基金资助项目(QMJJ202403))}, authors=null, keywords=[Keyword(id=1304140191984280235, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=CN, orderNo=1, keyword=通脉养心丸), Keyword(id=1304140192038806188, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=CN, orderNo=2, keyword=心肌缺血/再灌注损伤), Keyword(id=1304140192101720749, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=CN, orderNo=3, keyword=线粒体功能), Keyword(id=1304140192173023918, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=CN, orderNo=4, keyword=心肌细胞损伤), Keyword(id=1304140192269492911, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=CN, orderNo=5, keyword=过氧化物酶体增殖物激活受体γ共激活因子-1α), Keyword(id=1304140192378544816, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=EN, orderNo=1, keyword=Tongmai Yangxin Pill), Keyword(id=1304140192441459377, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=EN, orderNo=2, keyword=myocardial ischemia-reperfusion injury), Keyword(id=1304140192508568242, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=EN, orderNo=3, keyword=mitochondrial function), Keyword(id=1304140192558899891, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=EN, orderNo=4, keyword=cardiomyocyte injury), Keyword(id=1304140192630203060, tenantId=1146029695717560320, journalId=1302319053441957962, articleId=1304140191510323879, language=EN, orderNo=5, keyword=peroxisome proliferator-activated receptor gamma coactivator-1α)], refs=null, funds=null, companyList=null, figs=null, attaches=null, journal=Journal(id=1302309778002903112, delFlag=0, nameCn=中草药, nameEn=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, issn=0253-2670, eissn=null, cn=12-1108/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=cGpSKCP11AF8PAOcTXYWfg==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Traditional and Herbal Drugs, journalRemark=null, publicationField=null, createdTime=1788424446827, updatedTime=1788949289390, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=cGpSKCP11AF8PAOcTXYWfg==, picEn=Xw//kxUC3ON4eHxev0QLhQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1304511127375863983, language=CN, name=中草药, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289411, updatedTime=1788949289411, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304511127442972848, language=EN, name=Chinese Traditional and Herbal Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788949289427, updatedTime=1788949289427, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://www.tiprpress.com/zcy/author/login, submissionEditorUrl=https://www.tiprpress.com/zcy/editor/login, submissionReviewUrl=https://www.tiprpress.com/zcy/reviewer/login, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1302319053441957962, websiteList=[Website(id=1302319176408912052, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/CN, language=CN, createTime=1788426687576, createBy=18614031015, updateTime=1788427346252, updateBy=18614031015, name=中草药-中文, tplId=1146099689490845704, title=中草药, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322043651904087, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=articleTextType, value=kx, createTime=1788427371180, updateTime=1788427371180, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043593183828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=banner, value=null, createTime=1788427371166, updateTime=1788427371166, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043672875610, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=grayFlag, value=0, createTime=1788427371185, updateTime=1788427371185, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043584795219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427371164, updateTime=1788427371164, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043689652828, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=minRunFlag, value=0, createTime=1788427371189, updateTime=1788427371189, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043643515478, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/CN/file/pic, createTime=1788427371178, updateTime=1788427371178, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043681264219, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=silenceFlag, value=0, createTime=1788427371187, updateTime=1788427371187, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043601572437, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1788427371168, updateTime=1788427371168, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043660292696, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeColor, value=null, createTime=1788427371182, updateTime=1788427371182, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322043668681305, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176408912052, code=themeStyle, value=null, createTime=1788427371184, updateTime=1788427371184, creator=18614031015, updator=18614031015)]), Website(id=1302319176715096246, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1302319053441957962, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zcy/EN, language=EN, createTime=1788426687649, createBy=18614031015, updateTime=1788427341161, updateBy=18614031015, name=中草药-英文, tplId=1146101810881728533, title=Chinese Traditional and Herbal Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1302322015206134340, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=articleTextType, value=kx, createTime=1788427364398, updateTime=1788427364398, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015185162817, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=banner, value=null, createTime=1788427364393, updateTime=1788427364393, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015227105863, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=grayFlag, value=0, createTime=1788427364403, updateTime=1788427364403, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015176774208, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=logo, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic?fileId=uiD1gpiRqR++OLOz4iKzDg==, createTime=1788427364391, updateTime=1788427364391, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015239688777, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=minRunFlag, value=0, createTime=1788427364406, updateTime=1788427364406, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015201940035, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zcy/EN/file/pic, createTime=1788427364397, updateTime=1788427364397, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015235494472, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=silenceFlag, value=0, createTime=1788427364405, updateTime=1788427364405, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015193551426, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1788427364395, updateTime=1788427364395, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015214522949, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeColor, value=null, createTime=1788427364400, updateTime=1788427364400, creator=18614031015, updator=18614031015), WebsiteProps(id=1302322015218717254, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1302319176715096246, code=themeStyle, value=null, createTime=1788427364401, updateTime=1788427364401, creator=18614031015, updator=18614031015)])], journalTitle=中草药, weixinUrl=null, journalUrl=https://www.tiprpress.com/zcy, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Traditional and Herbal Drugs, journalPhotoCn=cGpSKCP11AF8PAOcTXYWfg==, journalPhotoEn=Xw//kxUC3ON4eHxev0QLhQ==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.03.012, detailUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2026.03.012, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zcy/CN/PDF/10.7501/j.issn.0253-2670.2026.03.012, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zcy/EN/PDF/10.7501/j.issn.0253-2670.2026.03.012, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1788860851409, fullTextJson=null, articleText=null, reference=Du B X, Fu Q, Yang Q, et al. Different types of cell death and their interactions in myocardial ischemia-reperfusion injury [J]. Cell Death Discov, 2025, 11(1): 87.
Lei P, Mwangi C N, Cao Y L, et al. Investigating the mechanism of action of Danhong Injection and its components against myocardial ischemia-reperfusion injury [J]. Acupunct Herb Med, 2023, 3(3): 213-226.
Chen R, Meng K, Wang C J, et al. Effects of Tongmai Yangxin Pills on ventricular remodeling in myocardial ischemia-reperfusion rats [J]. Acupunct Herb Med, 2023, 3(2): 126-136.
Zhao F, Cheng W, Wu D, et al. Hydroxysafflor yellow A ameliorates myocardial ischemia/reperfusion injury by promoting MDH1-mediated mitochondrial metabolic homeostasis [J]. Phytomedicine, 2025, 144: 156868.
Kuznetsov A V, Javadov S, Margreiter R, et al. The role of mitochondria in the mechanisms of cardiac ischemia-reperfusion injury [J]. Antioxidants, 2019, 8(10): 454.
Qian L, Zhu Y L, Deng C, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases [J]. Signal Transduct Target Ther, 2024, 9(1): 50.
Yu L, Wang X, Lei Q N, et al. Tongmai Yangxin Pill alleviates myocardial ischemia/reperfusion injury by regulating mitochondrial fusion and fission through the estrogen receptor alpha/peroxisome proliferator-activated receptor gamma coactivator-1 alpha signaling pathway [J]. J Ethnopharmacol, 2025, 345: 119639.
Fan Y D, Liu J W, Miao J, et al. Anti-inflammatory activity of the Tongmai Yangxin Pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway [J]. J Ethnopharmacol, 2021, 276: 114106.
Ghanta S N, Kattamuri L P V, Odueke A, et al. Molecular insights into ischemia-reperfusion injury in coronary artery disease: Mechanisms and therapeutic implications: A comprehensive review [J]. Antioxidants, 2025, 14(2): 213.
Heusch G. Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease [J]. Med, 2024, 5(1): 10-31.
Praharaj P P, Patra S, Singh A, et al. CLU (clusterin) and PPARGC1A/PGC1α coordinately control mitophagy and mitochondrial biogenesis for oral cancer cell survival [J]. Autophagy, 2024, 20(6): 1359-1382.
Guo R, Liu N N, Liu H, et al. High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3 [J]. Phytomedicine, 2020, 68: 153171.
Tao S, Huang Y, Chen Z, et al. Rapid identification of anti-inflammatory compounds from Tongmai Yangxin Pills by liquid chromatography with high-resolution mass spectrometry and chemometric analysis [J]. J Sep Sci, 2015, 38(11): 1881-1893.
苗冬青, 李霞, 李媛, 等. 甘草酸抑制O-GlcNAc糖基化修饰对高糖诱导的小鼠肾系膜细胞和足细胞线粒体自噬的影响 [J/OL]. 西安交通大学学报: 医学版, (2025-10-28) [2025-11-03]. https://link.cnki.net/urlid/61. 1399.R.20251028.1409.003
Wang Y X, Wang X L, Wang J R, et al. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Tongmai Yangxin Pill on ventricular remodeling in acute anterior STEMI patients after primary PCI [J]. Phytomedicine, 2024, 135: 156133.
Wang Y X, Wang X L, Wang J R, et al. Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: Study protocol for a double-blind, randomized controlled trial [J]. Trials, 2020, 21(1): 287.
Cai X M, Du J, Li L, et al. Clinical metabolomics analysis of therapeutic mechanism of Tongmai Yangxin Pill on stable angina [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2018, 1100/1101: 106-112.
Liu L J, Zhu G H, Luo H Y, et al. Tongmai Yangxin Pill combined with metoprolol or metoprolol alone for the treatment of symptomatic premature ventricular complex: A multicenter, randomized, parallel-controlled clinical study [J]. J Geriatr Cardiol, 2022, 19(4): 284-291.
Chen R, Chen T, Wang T Q, et al. Tongmai Yangxin Pill reduces myocardial no-reflow by regulating apoptosis and activating PI3K/Akt/eNOS pathway [J]. J Ethnopharmacol, 2020, 261: 113069.
廖佳伟, 金晨, 陈志 等. 鸡血藤化学成分、药理作用研究进展及其质量标志物(Q-Marker)预测 [J]. 中草药, 2023, 54(20): 6866-6877.
Liu X, Wang P Y, Tang S Q, et al. Mechanistic insights into myricetin-regulated autophagy via the PI3K/Akt and PINK1/Parkin pathway in diabetic kidney disease treatment [J]. J Ethnopharmacol, 2026, 355(Pt A): 120613.
Liu B H, Xu C Z, Liu Y, et al. Mitochondrial quality control in human health and disease [J]. Mil Med Res, 2024, 11(1): 32.
Callender L A, Schroth J, Carroll E C, et al. GATA3 induces mitochondrial biogenesis in primary human CD4+ T cells during DNA damage [J]. Nat Commun, 2021, 12: 3379.
Wang S L, Long H J, Hou L J, et al. The mitophagy pathway and its implications in human diseases [J]. Signal Transduct Target Ther, 2023, 8(1): 304.
Lin Y Y, Zhan M Z, Chen X Q, et al. Biological function of EPHB4 in the aging process of vascular endothelial cells: MtDNA molecular mechanism and MAPK/PGC-1/TFAM signaling pathway [J]. Int J Biol Macromol, 2025, 293: 138536.
Bekhite M, González-Delgado A, Hübner S, et al. The role of ceramide accumulation in human induced pluripotent stem cell-derived cardiomyocytes on mitochondrial oxidative stress and mitophagy [J]. Free Radic Biol Med, 2021, 167: 66-80.
Rawat P S, Jaiswal A, Khurana A, et al. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management [J]. Biomed Pharmacother, 2021, 139: 111708.
Tian L, Cao W J, Yue R J, et al. Pretreatment with Tilianin improves mitochondrial energy metabolism and oxidative stress in rats with myocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1 alpha signaling pathway [J]. J Pharmacol Sci, 2019, 139(4): 352-360.
Ramachandra C J A, Hernandez-Resendiz S, Crespo-Avilan G E, et al. Mitochondria in acute myocardial infarction and cardioprotection [J]. EBio Med, 2020, 57: 102884.)
收藏切换
通脉养心丸通过增强PGC-1α介导的线粒体功能减轻心肌缺血再灌注损伤
收藏切换
PDF下载
中草药 | 药理与临床 2026,57(3): 925-934
收起
收藏切换
中草药 |药理与临床 2026 , 57 (3) : 925 -934
通脉养心丸通过增强PGC-1α介导的线粒体功能减轻心肌缺血再灌注损伤
全屏
于鲁1, 王旭2, 刘雨桐1, 高杉1, 于春泉1, 李琳1
作者信息
    1 天津中医药大学, 天津 301617;
    2 河北工程大学附属医院, 河北 邯郸 056000
通讯作者:
于春泉
作者简介:
于鲁: 于鲁,博士研究生,研究方向为中医药治疗心脑血管疾病临床与基础研究。E-mail:yuluyulu2021@163.com
Tongmai Yangxin Pill mitigates myocardial ischemia-reperfusion injury through enhancement of PGC-1α-mediated mitochondrial function
  • YU Lu, WANG Xu, LIU Yutong, GAO Shan, YU Chunquan, LI Lin
  • Affiliations
    doi: 10.7501/j.issn.0253-2670.2026.03.012
    文章导航
    收藏切换
    目的 阐明通脉养心丸通过调节过氧化物酶体增殖物激活受体γ共激活因子-1α(peroxisome proliferator-activated receptor gamma coactivator-1α,PGC-1α)介导的线粒体功能从而发挥心肌缺血/再灌注损伤(myocardial ischemia-reperfusion injury,MI/RI)保护作用的机制。方法 构建缺氧复氧(hypoxia-reoxygenation,H/R)心肌细胞模型,给予通脉养心丸干预后,采用DCFH-DA和MitoSOXTM Red荧光探针检测细胞内活性氧(reactive oxygen species,ROS)水平;采用增强型三磷酸腺苷(adenosine triphosphate,ATP)检测试剂盒检测ATP水平;JC-1染色观察线粒体膜电位变化;采用Seahorse XF细胞线粒体压力测试分析线粒体呼吸功能;Mitotracker与透射电镜观察线粒体的形态与结构变化;采用Western blotting与qRT-PCR检测线粒体融合分裂[线粒体融合素1(mitofusin 1,Mfn1)、线粒体融合素2(mitofusin 2,Mfn2)、线粒体分裂蛋白1(fission 1,Fis1)、动力相关蛋白1(dynamin-related protein 1,Drp1)]、生物合成[核呼吸因子1&(nuclear respiratory factor 1,Nrf1)、线粒体转录因子A(mitochondrial transcription factor A,&TFAM)、线粒体DNA(mitochondrial DNA,mtDNA)拷贝数]及自噬[Beclin1、PTEN诱导激酶1(PTEN-induced putative kinase 1,PINK1)、帕金蛋白(Parkin)、p62]相关蛋白和基因的表达水平。通过PGC-1α siRNA转染实验进一步观察通脉养心丸对PGC-1α沉默表达后H9c2细胞上述功能的影响。结果 与模型组比较,通脉养心丸显著增强线粒体ATP合成(P<0.01),改善线粒体膜电位(P<0.01),减少氧化应激(P<0.01),并促进线粒体自噬(P<0.05、0.01)。沉默PGC-1α后,通脉养心丸对线粒体功能的保护作用显著削弱(P<0.05、0.01)。结论 通脉养心丸能够通过PGC-1α调控线粒体的生物合成、动态平衡及自噬,从而有效改善MI/RI引发的线粒体功能紊乱与形态结构变化。揭示了PGC-1α作为线粒体功能调控的核心因子,其在MI/RI中的潜在治疗价值,为MI/RI的治疗提供了新的思路。
    通脉养心丸  /  心肌缺血/再灌注损伤  /  线粒体功能  /  心肌细胞损伤  /  过氧化物酶体增殖物激活受体γ共激活因子-1α
    Objective To elucidate how Tongmai Yangxin Pill (通脉养心丸, TMYX) confers cardioprotective effects during myocardial ischemia/reperfusion injury (MI/RI) through the regulation of peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α)-mediated mitochondrial function. Methods A hypoxia-reoxygenation (H/R) model in cardiomyocytes was established. After intervention with TMYX, intracellular reactive oxygen species (ROS) levels were measured using DCFH-DA and MitoSOXTM red fluorescent probes. Cellular adenosine triphosphate (ATP) content was quantified using an enhanced ATP assay kit. Changes in mitochondrial membrane potential were evaluated by JC-1 staining. Mitochondrial respiratory function was assessed using Seahorse XF cell mitochondrial stress test. Mitochondrial morphology and ultrastructural alterations were examined using MitoTracker staining and transmission electron microscopy. Western blotting and qRT-PCR were used to determine the expression levels of proteins and genes associated with mitochondrial fusion and fission [mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), fission 1 (Fis1), dynamin-related protein 1 (Drp1)], biogenesis [nuclear respiratory factor 1 (Nrf1), mitochondrial transcription factor A (TFAM), mitochondrial DNA (mtDNA) copy number] and autophagy [Beclin1, PTEN-induced putative kinase 1 (PINK1), Parkin, p62]. To further investigate the effects of TMYX on the above-mentioned functions of H9c2 cells after PGC-1α silencing expression through PGC-1α siRNA transfection experiment. Results Compared with model group, TMYX significantly enhanced mitochondrial ATP synthesis (P < 0.01), improved mitochondrial membrane potential (P < 0.01), reduced oxidative stress (P < 0.01), and promoted mitochondrial autophagy (P < 0.05, 0.01). After silencing PGC-1α, the protective effect of TMYX on mitochondrial function was significantly weakened (P < 0.05, 0.01). Conclusion TMYX could effectively improve mitochondrial dysfunction and morphological changes induced by MI/RI by regulating mitochondrial biosynthesis, dynamic balance and autophagy through PGC-1α. This study reveals PGC-1α as a core factor regulating mitochondrial function and its potential therapeutic value in MI/RI, providing new ideas for the treatment of MI/RI.
    Tongmai Yangxin Pill  /  myocardial ischemia-reperfusion injury  /  mitochondrial function  /  cardiomyocyte injury  /  peroxisome proliferator-activated receptor gamma coactivator-1α
    于鲁, 王旭, 刘雨桐, 高杉, 于春泉, 李琳. 通脉养心丸通过增强PGC-1α介导的线粒体功能减轻心肌缺血再灌注损伤. 中草药, 2026 , 57 (3) : 925 -934 . DOI: 10.7501/j.issn.0253-2670.2026.03.012
    YU Lu, WANG Xu, LIU Yutong, GAO Shan, YU Chunquan, LI Lin. Tongmai Yangxin Pill mitigates myocardial ischemia-reperfusion injury through enhancement of PGC-1α-mediated mitochondrial function[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (3) : 925 -934 . DOI: 10.7501/j.issn.0253-2670.2026.03.012

      国家自然科学基金青年科学基金资助项目(82104565);天津中医药大学组分中药国家重点实验室青苗基金资助项目(QMJJ202403)

    参考文献 引证文献
    排序方式:
    Du B X, Fu Q, Yang Q, et al. Different types of cell death and their interactions in myocardial ischemia-reperfusion injury [J]. Cell Death Discov, 2025, 11(1): 87.
    Lei P, Mwangi C N, Cao Y L, et al. Investigating the mechanism of action of Danhong Injection and its components against myocardial ischemia-reperfusion injury [J]. Acupunct Herb Med, 2023, 3(3): 213-226.
    Chen R, Meng K, Wang C J, et al. Effects of Tongmai Yangxin Pills on ventricular remodeling in myocardial ischemia-reperfusion rats [J]. Acupunct Herb Med, 2023, 3(2): 126-136.
    Zhao F, Cheng W, Wu D, et al. Hydroxysafflor yellow A ameliorates myocardial ischemia/reperfusion injury by promoting MDH1-mediated mitochondrial metabolic homeostasis [J]. Phytomedicine, 2025, 144: 156868.
    Kuznetsov A V, Javadov S, Margreiter R, et al. The role of mitochondria in the mechanisms of cardiac ischemia-reperfusion injury [J]. Antioxidants, 2019, 8(10): 454.
    Qian L, Zhu Y L, Deng C, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases [J]. Signal Transduct Target Ther, 2024, 9(1): 50.
    Yu L, Wang X, Lei Q N, et al. Tongmai Yangxin Pill alleviates myocardial ischemia/reperfusion injury by regulating mitochondrial fusion and fission through the estrogen receptor alpha/peroxisome proliferator-activated receptor gamma coactivator-1 alpha signaling pathway [J]. J Ethnopharmacol, 2025, 345: 119639.
    Fan Y D, Liu J W, Miao J, et al. Anti-inflammatory activity of the Tongmai Yangxin Pill in the treatment of coronary heart disease is associated with estrogen receptor and NF-κB signaling pathway [J]. J Ethnopharmacol, 2021, 276: 114106.
    Ghanta S N, Kattamuri L P V, Odueke A, et al. Molecular insights into ischemia-reperfusion injury in coronary artery disease: Mechanisms and therapeutic implications: A comprehensive review [J]. Antioxidants, 2025, 14(2): 213.
    Heusch G. Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease [J]. Med, 2024, 5(1): 10-31.
    Praharaj P P, Patra S, Singh A, et al. CLU (clusterin) and PPARGC1A/PGC1α coordinately control mitophagy and mitochondrial biogenesis for oral cancer cell survival [J]. Autophagy, 2024, 20(6): 1359-1382.
    Guo R, Liu N N, Liu H, et al. High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3 [J]. Phytomedicine, 2020, 68: 153171.
    Tao S, Huang Y, Chen Z, et al. Rapid identification of anti-inflammatory compounds from Tongmai Yangxin Pills by liquid chromatography with high-resolution mass spectrometry and chemometric analysis [J]. J Sep Sci, 2015, 38(11): 1881-1893.
    苗冬青, 李霞, 李媛, 等. 甘草酸抑制O-GlcNAc糖基化修饰对高糖诱导的小鼠肾系膜细胞和足细胞线粒体自噬的影响 [J/OL]. 西安交通大学学报: 医学版, (2025-10-28) [2025-11-03]. https://link.cnki.net/urlid/61. 1399.R.20251028.1409.003
    Wang Y X, Wang X L, Wang J R, et al. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Tongmai Yangxin Pill on ventricular remodeling in acute anterior STEMI patients after primary PCI [J]. Phytomedicine, 2024, 135: 156133.
    Wang Y X, Wang X L, Wang J R, et al. Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: Study protocol for a double-blind, randomized controlled trial [J]. Trials, 2020, 21(1): 287.
    Cai X M, Du J, Li L, et al. Clinical metabolomics analysis of therapeutic mechanism of Tongmai Yangxin Pill on stable angina [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2018, 1100/1101: 106-112.
    Liu L J, Zhu G H, Luo H Y, et al. Tongmai Yangxin Pill combined with metoprolol or metoprolol alone for the treatment of symptomatic premature ventricular complex: A multicenter, randomized, parallel-controlled clinical study [J]. J Geriatr Cardiol, 2022, 19(4): 284-291.
    Chen R, Chen T, Wang T Q, et al. Tongmai Yangxin Pill reduces myocardial no-reflow by regulating apoptosis and activating PI3K/Akt/eNOS pathway [J]. J Ethnopharmacol, 2020, 261: 113069.
    廖佳伟, 金晨, 陈志 等. 鸡血藤化学成分、药理作用研究进展及其质量标志物(Q-Marker)预测 [J]. 中草药, 2023, 54(20): 6866-6877.
    Liu X, Wang P Y, Tang S Q, et al. Mechanistic insights into myricetin-regulated autophagy via the PI3K/Akt and PINK1/Parkin pathway in diabetic kidney disease treatment [J]. J Ethnopharmacol, 2026, 355(Pt A): 120613.
    Liu B H, Xu C Z, Liu Y, et al. Mitochondrial quality control in human health and disease [J]. Mil Med Res, 2024, 11(1): 32.
    Callender L A, Schroth J, Carroll E C, et al. GATA3 induces mitochondrial biogenesis in primary human CD4+ T cells during DNA damage [J]. Nat Commun, 2021, 12: 3379.
    Wang S L, Long H J, Hou L J, et al. The mitophagy pathway and its implications in human diseases [J]. Signal Transduct Target Ther, 2023, 8(1): 304.
    Lin Y Y, Zhan M Z, Chen X Q, et al. Biological function of EPHB4 in the aging process of vascular endothelial cells: MtDNA molecular mechanism and MAPK/PGC-1/TFAM signaling pathway [J]. Int J Biol Macromol, 2025, 293: 138536.
    Bekhite M, González-Delgado A, Hübner S, et al. The role of ceramide accumulation in human induced pluripotent stem cell-derived cardiomyocytes on mitochondrial oxidative stress and mitophagy [J]. Free Radic Biol Med, 2021, 167: 66-80.
    Rawat P S, Jaiswal A, Khurana A, et al. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management [J]. Biomed Pharmacother, 2021, 139: 111708.
    Tian L, Cao W J, Yue R J, et al. Pretreatment with Tilianin improves mitochondrial energy metabolism and oxidative stress in rats with myocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1 alpha signaling pathway [J]. J Pharmacol Sci, 2019, 139(4): 352-360.
    Ramachandra C J A, Hernandez-Resendiz S, Crespo-Avilan G E, et al. Mitochondria in acute myocardial infarction and cardioprotection [J]. EBio Med, 2020, 57: 102884.
    2026年第57卷第3期
    PDF下载
    25
    8
    引用本文
    BibTeX
    文章信息
    doi: 10.7501/j.issn.0253-2670.2026.03.012
    • 接收时间:2025-10-04
    • 首发时间:2026-09-08
    补充材料
    相关文章
    文章信息
    作者
    出版历史
    • 收稿日期:2025-10-04
    基金
    作者信息
    参考文献
    分享链接
    https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.03.012
    分享至
    全文二维码

    扫描看全文

    引用本文
    BibTeX
    本文的引用情况
    2种不同金属材料的力学参数

    Family
    属数
    Number of
    genus
    种数
    Number of
    species
    占总种数比例
    Percentage of
    total species (%)

    Genus
    种数
    Number of
    species
    占总种数比例
    Percentage of total
    species (%)
    鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
    小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
    多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
    红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
    小菇属 Mycena 11 5.26
    光柄菇属 Pluteus 5 2.39
    红菇属 Russula 17 8.13
    栓菌属 Trametes 5 2.39
    关闭全屏